New developments in the biology and treatment of HIV.
作者信息
Bushman F, Landau N R, Emini E A
机构信息
Infectious Disease Laboratory, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
出版信息
Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11041-2. doi: 10.1073/pnas.95.19.11041.
Abstract
摘要
相似文献
1
New developments in the biology and treatment of HIV.HIV生物学与治疗的新进展
Proc Natl Acad Sci U S A. 1998 Sep 15;95(19):11041-2. doi: 10.1073/pnas.95.19.11041.
2
[HIV: highly promising results with the new protease inhibitor].[艾滋病病毒：新型蛋白酶抑制剂取得极有前景的成果]
Dtsch Med Wochenschr. 1996 Aug 23;121(34-35):A35.
3
Early events of HIV infection as targets for antiviral agents.作为抗病毒药物靶点的HIV感染早期事件。
Ann N Y Acad Sci. 1990;616:155-60. doi: 10.1111/j.1749-6632.1990.tb17836.x.
4
An approach to antiretroviral treatment of HIV disease. New approaches.一种针对HIV疾病的抗逆转录病毒治疗方法。新方法。
Hosp Pract (1995). 1995 Aug;30 Suppl 1:32-40.
5
[Protease inhibitors--new preparations for treatment of HIV infections].[蛋白酶抑制剂——治疗HIV感染的新制剂]
Ugeskr Laeger. 1998 Jan 19;160(4):451-6.
6
[Individualization of HIV-therapy].[艾滋病病毒治疗的个体化]
Internist (Berl). 1995 Jul;36(7 Suppl [individu]):1-4.
7
New developments in antiretroviral drug therapy for HIV infection.用于治疗HIV感染的抗逆转录病毒药物疗法的新进展。
AIDS Clin Rev. 1992:69-104.
8
[Discontinuation of antiretroviral treatment containing a protease inhibitor. Failure and tolerance].[含蛋白酶抑制剂的抗逆转录病毒治疗的中断。失败与耐受性]
Presse Med. 1999 Feb 27;28(8):402-4.
9
[Treatment of HIV/AIDS. New possibilities result in new problems].
Ugeskr Laeger. 1998 Jun 1;160(23):3371.
10
CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy.
AIDS. 1999 Apr 1;13(5):621-2. doi: 10.1097/00002030-199904010-00012.
引用本文的文献
1
Persistence of CMV-specific anti-HIV CAR T cells after adoptive immunotherapy.过继性免疫治疗后巨细胞病毒特异性抗HIV嵌合抗原受体T细胞的持久性。
J Virol. 2025 May 20;99(5):e0193324. doi: 10.1128/jvi.01933-24. Epub 2025 Apr 10.
2
CD4 immunophenotyping in HIV infection.HIV感染中的CD4免疫分型
Nat Rev Microbiol. 2008 Nov;6(11 Suppl):S7-15. doi: 10.1038/nrmicro1998.
3
Inhibition of highly productive HIV-1 infection in T cells, primary human macrophages, microglia, and astrocytes by Sargassum fusiforme.羊栖菜对T细胞、原代人巨噬细胞、小胶质细胞和星形胶质细胞中高效HIV-1感染的抑制作用。
AIDS Res Ther. 2006 May 25;3:15. doi: 10.1186/1742-6405-3-15.
4
Blockade of chemokine-induced signalling inhibits CCR5-dependent HIV infection in vitro without blocking gp120/CCR5 interaction.趋化因子诱导信号传导的阻断在体外抑制CCR5依赖性HIV感染，而不阻断gp120/CCR5相互作用。
Retrovirology. 2005 Apr 4;2:23. doi: 10.1186/1742-4690-2-23.
5
T cell signaling and apoptosis in HIV disease.HIV疾病中的T细胞信号传导与细胞凋亡
Immunol Res. 2003;27(2-3):247-60. doi: 10.1385/IR:27:2-3:247.
本文引用的文献
1
HIV entry and tropism: the chemokine receptor connection.HIV进入与嗜性：趋化因子受体联系
AIDS. 1997;11 Suppl A:S3-16.
2
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy.在高效抗逆转录病毒治疗期间存在可诱导的HIV-1潜伏库。
Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13193-7. doi: 10.1073/pnas.94.24.13193.
3
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy.在接受高效抗逆转录病毒治疗的患者中鉴定HIV-1储存库。
Science. 1997 Nov 14;278(5341):1295-300. doi: 10.1126/science.278.5341.1295.
4
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.尽管血浆病毒血症长期受到抑制，但仍出现具有复制能力的HIV病毒的恢复。
Science. 1997 Nov 14;278(5341):1291-5. doi: 10.1126/science.278.5341.1291.
5
HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro.HIV-1 cDNA整合：体外整合前复合物功能对HMG I(Y)蛋白的需求
Cell. 1997 Feb 21;88(4):483-92. doi: 10.1016/s0092-8674(00)81888-7.
6
HIV-1 protease inhibitors. A review for clinicians.人类免疫缺陷病毒1型蛋白酶抑制剂。临床医生综述
JAMA. 1997 Jan 8;277(2):145-53.
7
HIV cDNA integration: molecular biology and inhibitor development.HIV cDNA整合：分子生物学与抑制剂开发。
AIDS. 1996;10 Suppl A:S3-11.
8
Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection.HIV-1共受体的纯合缺陷导致一些多次暴露个体对HIV-1感染具有抗性。
Cell. 1996 Aug 9;86(3):367-77. doi: 10.1016/s0092-8674(00)80110-5.
9
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.一种双嗜性原发性HIV-1分离株，其利用融合素以及β趋化因子受体CKR-5、CKR-3和CKR-2b作为融合辅助因子。
Cell. 1996 Jun 28;85(7):1149-58. doi: 10.1016/s0092-8674(00)81314-8.
10
The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates.β趋化因子受体CCR3和CCR5促进原发性HIV-1分离株的感染。
Cell. 1996 Jun 28;85(7):1135-48. doi: 10.1016/s0092-8674(00)81313-6.
Zotero 插件